Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

Triple-negative breast cancer (TNBC) presents unique challenges due to its aggressive nature and limited treatment options. Black women are disproportionately affected by TNBC, experiencing higher incidence rates and poorer outcomes compared to other racial and ethnic groups. This study aims to evaluate disparities in access to quality cancer care for Black women with TNBC from the perspective …
Presented at the San Antonio Breast Cancer Symposium®- December 5-9, 2023.
December 7, 2023
You're invited to participate in Targeted Oncology's Community Case Forum on Thursday, December 7 at Grand Hyatt Nashville in Nashville, Tennessee. Healthcare Research Analytics® offers compensation of $750 to medical oncologists/hematologists for their consultative insights. After arriving at registration check-in, you'll spend some time networking with peers while enjoying small plates …
Expanding Access to Cellular and Bispecific Therapies Considerations and Recommendations SITC-0423-222 SITCancer.org | ACCC-Cancer.org 1 Table of Contents Recommendations Overview ..................................................................................................................................................................................... 2 …
NSCLC: Biomarker Testing & Targeted Therapy in Advanced/ Metastatic NSCLC targetedonc.com/events Register Today In this discussion we will discuss biomarker testing and an EGFR+ metastatic NSCLC case study. Join Targeted Oncology™ for a collaborative, small- group meeting designed around case-based clinical profiles and peer-dialogue led by an expert physician. This session offers …
Breast Cancer: Practice Updates in HR+, HER2 0 Metastatic Breast Cancer Regimens MODERATOR Dr. Joyce O’Shaughnessy Texas Oncology targetedonc.com/events Register Today We will discuss 2 cases that are designed to foster discussion of how we will integrate newly approved therapeutic options into treatment planning for HR+, HER2 IHC 0 metastatic Breast Cancer. Join Targeted …
December 6, 2023
The Wisconsin Association of Hematology and Oncology (WAHO) of invites you to enjoy a complimentary evening of cocktails and networking at our Meet & Greet Reception on Wednesday, December 6th. This is a great opportunity to meet and connect with local oncology professionals and attendees. You do not need to be a WAHO Member to participate! Feel free to bring along any colleagues or friends …
ACCC has developed an initiative to support health care providers in applying evidence-based treatment selection for patients with advanced/metastatic gastric cancer. Learn more.
Targeted Oncology’s Seating is limited, and registration will close when capacity is reached. Reserve your seat today! Optimizing Immunotherapeutic Approaches in the Treatment of Non-Small Cell Lung Cancer MODERATED BY John V. Heymach MD, PhD Therapeutic Sequencing for Unresectable HCC MODERATED BY Pierre Gholam, MD Stay informed on the latest research data in an informal, …
January 11, 2024 • 5:30 pm to 8:00 pm Ralph’s on the Park Explore the forefront of medical advancements in oncology and hematology with engaging talks by talented fellows. Topics will range from the latest breakthroughs in oncology to innovative approaches in medical education. Please note that individuals employed by pharmaceutical/ device manufacturers (including MSLs), consulting, or …
Nurses at this NCI-designated Comprehensive Cancer Center piloted an evidence-based project that engaged an immersive virtual reality experience to reduce fear and anxiety among patients with cancer receiving chemotherapy treatment.
The importance of care coordination in managing the adverse effects of cancer treatment and navigating patient challenges such as emotional distress, isolation, financial toxicity, and lower quality of life.
tools 70 OI | Vol. 38, No 6, 2023 | accc-cancer.org • On October 24, the FDA approved Tibsovo® (ivosidenib) (Servier, servier.us) for adult patients with relapsed or refractory myelo- dysplastic syndromes with a susceptible isocitrate dehydrogenase-1 mutation, as detected by an FDA-approved test. Drugs In the News • Daiichi Sankyo (daiichisankyo.com) announced that the FDA …
This multidisciplinary discussion seeks to develop a standardized framework that allows community oncologists to easily assess patients for CAR T-cell therapy, with a focus on large B cell lymphoma.
Learn how Dorcy Cancer Center at St Mary-Corwin Hospital in Pueblo, Colorado, developed and implemented the model tobacco cessation program.
CAR T-cell therapies have ushered in a new era of treatment options for patients with certain hematologic malignancies. Thus, it is important to make these therapies accessible and affordable.
action 68 OI | Vol. 38, No 6, 2023 | accc-cancer.org ACCC 40th National Oncology Conference The Association of Community Cancer Centers (ACCC) welcomed more than 600 attendees over a 3-day span (October 4-6) in Austin, Texas, for its 40th National Oncology Conference. Day 1 of the meeting included a pre-conference focused on the ACCC Financial Advocacy Network (left), an enlightening …
Standardization of Bereavement Care Across Oncology Institutions This publication is a benefit of membership Association of Community Cancer Centers Vol. 38 | No. 6 | 2023 Implementing a comprehensive tobacco cessation program | 30 Reducing patient anxiety with VR technology | 23 Pioneering a cancer program of the future | 13 ISSUES ONCOLOGY REIMAGINING …
ACCC partnered with the Hawaii Society of Clinical Oncology to conduct a landscape analysis of current regional activities, barriers, and interventions around the health care workforce shortage in Hawaii.
fast facts Strategies to Improve Employee Attraction and Retention 1. Ensure onboarding is a part of your overall engagement strategy. Guide new employees through the entire range of benefits and support services, ensuring they understand not only their health benefits but also financial assistance, family planning, and disability support. 2. Create meaningful …